NZ Multiple Myeloma Research Review Issue 5

In this issue:

Late relapses following RIC allogeneic HSCT in MM
EMD portends poor prognosis in MM
Thalidomide in newly diagnosed elderly MM
Immune system analysis of controlled MM
Melphalan+prednisone ±bortezomib in previously untreated MM
PSMB variants in bortezomibvs. dexamethasone-treated relapsed MM
SC vs. IV bortezomib in relapsed MM
VTD ±cyclophosphamide induction in previously untreated MM
Long-term outcomes of successive TT trials for MM
Zoledronic acid ±thalidomide in asymptomatic MM

Please login below to download this issue (PDF)

Subscribe